Showing 26-30 of 34 data studies & next generation registries:
AI & Big Data: Transforming Real-World Evidence’s Impact on Decision Making

November 28, 2017 – Dr. Richard Gliklich As artificial intelligence and advanced analytics are increasingly lauded for uses in life sciences and healthcare, it’s becoming difficult to differentiate between the different terms, to understand what is real and what is hype, and to understand how to best leverage these technologies for advancing real-world evidence and[…]

Big Data Reveals 1 out of 6 ER Visits in Q2 2017 Opioid Related

BIG DATA REVEALS 1 OUT OF 6 ER VISITS IN Q2 2017 OPIOID RELATED OM1 launches a prototype for tracking the public health crisis in near real time BOSTON, November 27, 2017 — OM1, a leading AI health outcomes and data company focused on making healthcare more measured, precise and pre-emptive, today announced it has[…]

September 19 – Big Data and Cognitive Computing: The Next Generation of RWE for Rheumatology & Related Immunologic Disorders

September 19, 2017 – 10 am ET Join Kathryn Starzyk, Senior Director of Research and Epidemiology, at OM1, as she discusses the evolving role of big data and cognitive computing in generating real-world evidence for rheumatology and related immunologic disorders. This session will explore how advanced technologies and approaches can be applied to support real-world[…]

Big Ideas for Big Data Analytics in Real-World Evidence

Published August 9  – by HealthEconomics.com Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). HealthEcoOM1logonomics.Com asked Dr. Gliklich to shares his views on major transformational changes in evidence development and how these will[…]